Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/06/2003US20030045492 Comprising contacting skin of the animal with a vector that expresses a nucleic acid molecule encoding the gene product, in an amount effective to induce the response.
03/06/2003US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present
03/06/2003US20030045467 Administering in combination with an oil-based carrier for the prevention and treatment of diabetes type 1
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030044975 Cytokine-binding domain for use in the treatment of asthma and thrombocytopenia
03/06/2003US20030044962 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044953 Novel telomerase
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044936 Peptide repeat immunogens
03/06/2003US20030044915 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
03/06/2003US20030044901 Polypeptide for use in animal models associated with human therapeutics
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044891 Nucleotide sequences coding mutant protein for use in generation of vaccine which prevents bordetella infections
03/06/2003US20030044859 Reagents and methods useful for detecting diseases of the breast
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044841 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044815 Nucleotide sequences coding polypeptide for use in the diagnosis and classification of cancer
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044809 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
03/06/2003US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide
03/06/2003US20030044450 Oral vaccines
03/06/2003US20030044430 Pertussis toxin gene: cloning and expression of protective antigen
03/06/2003US20030044429 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer
03/06/2003US20030044428 Significantly improves ability of many HIV infected individuals to maintain suppression of HIV replication to low levels for an extended period of time; AIDS therapy
03/06/2003US20030044426 Attenuated pestiviruses
03/06/2003US20030044425 Adjuvant complex composed of bacterial outer membrane protein proteosomes complexed to bacterial liposaccharide; immunogenic compositions, vaccines and immunotherapeutics
03/06/2003US20030044422 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use
03/06/2003US20030044419 Use of reagents derived from nucleic acid and amino acid sequences of Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines
03/06/2003US20030044414 Vaccine which neutralizes bacteria or protozoa
03/06/2003US20030044410 Neutralization interferons, tumor necrosis factor
03/06/2003US20030044409 Complexing to epitope; cancer immunotherapy
03/06/2003US20030044408 Surface modification for improving biocompatibility
03/06/2003US20030044406 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents
03/06/2003US20030044394 Activating lymphocytes
03/06/2003US20030044393 Method for increasing tumor cell immunogenicity using heat shock protein
03/06/2003US20030044384 Treatment of neoplasms with viruses
03/06/2003CA2496180A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003CA2494870A1 Methods for inhibiting angiogenesis
03/06/2003CA2459141A1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
03/06/2003CA2458854A1 Helicobacter pylori vaccination
03/06/2003CA2458627A1 Human cdr-grafted antibody and antibody fragment thereof
03/06/2003CA2458567A1 Method and apparatus using idstm for multi-agent therapy
03/06/2003CA2458559A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003CA2458394A1 Lipophilic drug compositions
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2458236A1 Gpi-anchored cytokines
03/06/2003CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003CA2457890A1 Vaccine using papillomavirus e proteins delivered by viral vector
03/06/2003CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003CA2457514A1 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions
03/06/2003CA2451740A1 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/05/2003EP1288304A2 Self-assembled, defective, non-self-propagating viral particles
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288298A2 TRNA synthetase from Staphylococcus aureus
03/05/2003EP1288292A1 Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses.
03/05/2003EP1288291A1 Method of amplifying natural killer t cells
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1287832A2 Use of leukemia inhibitory factor antagonist
03/05/2003EP1287831A1 Antigen mimotopes and vaccine against cancerous diseases
03/05/2003EP1287827A1 Immunopotentiator
03/05/2003EP1287357A2 Artificial antigen presenting cells and methods of use thereof
03/05/2003EP1287161A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
03/05/2003EP1287152A2 Human-bovine chimeric respiratory syncytial virus vaccines
03/05/2003EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
03/05/2003EP1287141A2 Extracellular messengers
03/05/2003EP1287140A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
03/05/2003EP1287137A2 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
03/05/2003EP1287132A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287033A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
03/05/2003EP1287031A2 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287026A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287024A2 Virulence genes, proteins, and their use
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286705A2 Bioconjugates of nanoparticles as radiopharmaceuticals
03/05/2003EP1286703A2 Methods and compounds for controlled release of recombinant parvovirus vectors
03/05/2003EP1286696A1 Outer membrane vesicle vaccine against disease caused by neisseria meningitidis serogroup a and process for the production thereof
03/05/2003EP1286695A1 Antigenic composition comprising a polycationic peptide and inosine and cytosine
03/05/2003EP1286694A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286692A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
03/05/2003EP1286689A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
03/05/2003EP1286686A2 Methods for preventing strokes by inducing tolerance to e-selectin
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
03/05/2003EP0971692B1 Specific magnetosome, method for the production and use thereof
03/05/2003EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0830143B1 Use of leukemia inhibitory factor and endothelin antagonists
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0602126B1 Immunoglobulin variants for specific fc epsilon receptors
03/05/2003CN1400907A 9M-negative EHV-mutants
1 ... 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 ... 1823